To investigate the clinical features of early-onset primary torsion dystonia (EO-PTD), 57 consecutive genetically characterized patients with onset before 21 years were studied. Sex, ethnic origin, family history of dystonia, age at onset, disease duration, site of dystonia onset and distribution at latest examination, dystonia progression, time to generalization, and motor disability were noted. The 14 patients (25%) with GAG deletion (904_906/907_909delGAG) in the DYT1 gene were compared with the remaining non-DYT1 patients. Cranial involvement was present in 49% of non-DYT1 cases, but only 14% of DYT1 cases; non-DYT1 patients were younger at time of generalization. DYT1 cases had features similar to sporadic non-DYT1 cases but differed markedly from familial non-DYT1 cases, the latter having later age at onset, less common limb onset, more frequent cervical involvement, and slower progression than DYT1 PTD. These findings indicate that non-DYT1 forms of EO-PTD differ clinically from those of DYT1 forms. Cranial involvement before 21 years of age is the strongest predictor of non-DYT1 status. Positive family history and cervical involvement are associated with less severe progression in non-DYT1 forms.
Primary torsion dystonia (PTD) is one of several disorders characterized by sustained muscle contractions usually producing body or limb twisting with abnormal postures or repetitive movements. 1, 2 Early-onset primary dystonia (EO-PTD) is the most severe form of PTD and often aggregates in families. 3, 4 Mutations in the DYT1 gene are often responsible for EO-PTD; the most common defect being a GAG deletion in the coding region. 5 The DYT1 gene encodes torsinA, 6 a protein of unclear function that interacts with endocellular membranes and may regulate vesicular exocytosis. 7 The common presentation of DYT1 PTD is limb onset with progressive generalization that spares cranial muscles, although it is increasingly recognized that DYT1 PTD is clinically heterogeneous. 8 Although DYT1 gene defects are responsible for a large proportion of EO-PTD, 9 many, particularly non-Jewish cases, are not linked to the DYT1 gene. 10 Information on non-DYT1 EO-PTD forms is scanty, but its phenotype partially overlaps with the DYT1 phenotype, raising the question as to whether specific clinical features are associated with the various genetically distinct forms. 9, 11 We investigated clinical features in 57 consecutive genetically characterized EO-PTD patients, seeking to better define non-DYT1 forms and identify systematic clinical differences between them and DYT1 forms.
PATIENTS AND METHODS
We recruited 57 consecutive patients (or probands in familial cases) diagnosed with EO-PTD at two Italian centers: Gemelli Hospital, Rome, and the Besta Neuro-logical Institute of Milan. All fulfilled the diagnostic criteria for definite PTD 12 and in particular had symptoms onset before 21 years of age. [13] [14] [15] Nonprimary dystonia was excluded from history (delivery, early postnatal life, development, etc.), clinical examination, brain magnetic resonance imaging, response to a 1-month trial of levodopa, and screening for metabolic diseases and other hereditary neurodegenerative syndromes. 16 No patient had ataxia, Parkinsonism, eye movement deficits, or neuropathy. All were treated according to established therapeutic protocols with high-dose anticholinergics 17 or baclofen. 18 Follow-up evaluations were performed twice a year and included neurological examination, dystonia assessment, 19 and video recordings (see Video, Segment 1).
The following were recorded for each patient: sex, ethnic origin, family history of dystonia, age of dystonia onset, site of dystonia onset, distribution at latest examination, and time to generalization. History of seizures, head or limb trauma, and febrile illness before or during disease course was also noted.
Dystonia severity and resulting disability were assessed using the Burke & Fahn-Marsden dystonia rating scale, consisting of movement and disability subscales. 19 Dystonia progression from onset site to other body areas was evaluated retrospectively, by ascertaining the mean number of body sites involved each year. Cases were considered familial when at least one first-or seconddegree family member was diagnosed with PTD by direct evaluation.
All patients gave written consent for DNA analysis. DNA was extracted from peripheral blood leukocytes by standard procedures. In all cases, the DYT1 gene was analyzed to detect GAG 6 deletions (904_906/ 907_909delGAG; Glu 302/303del) and the 18-bp deletion (966_983del; Phe323_Tyr328del). 20 
Statistical Analysis
Continuous data were expressed as means (ϮSD) and compared by one-way analysis of variance (ANOVA) and Student t test. Pearson's correlation coefficient was used to assess relationships between continuous data. Dichotomous data were compared by 2 test using the Fisher or the Yates corrections as appropriate. Disease progression was analyzed by repeated-measures ANOVA of the mean number of body areas progressively affected by dystonia during the disease course. Dystonia spread was assessed as the time from disease onset to involvement of two, three, and four body parts or generalization. Life table dystonia progression curves were compared using Gehan's Wilcoxon test. The likelihood of genotype prediction based on site of onset and specificity and sensitivity of each site of onset was determined. 21 
RESULTS
The series consisted of 18 women and 39 men. Mean age at onset was 9.1 Ϯ 4.2 years (range, 2-18 years); mean disease duration was 17.9 Ϯ 12.1 years (range, 1-55 years). Mean age at most recent examination was 26.8 Ϯ 13.4 years (range, 7-67 years). At most recent examination, dystonia was generalized in 42 patients, segmental in 9, focal in 5, and multifocal in 1. A total of 45 patients had a sporadic form, and 12 were index cases of familiar forms in 12 unrelated families. No patient reported head or limb trauma, seizures, or severe febrile illness at onset or during follow-up.
DYT1 Cases
The DYT1 GAG deletion was found in 14 patients (25%, 12 men, 2 women; ratio, 6:1), 13 of whom were Caucasian and 1 a Sephardic Jew. The 18-bp deletion was not found. Mean age at onset was 10.1 Ϯ 3.7 years (range, 6 -18 years). There were 13 patients (93%) who reported limb onset (lower in 6, upper in 7), and 1 had axial onset. Patients with upper limb onset had comparable onset age to those with lower limb onset.
At latest examination, mean disease duration was 24.0 Ϯ 13.5 years (range, 1-55 years); 13 (93%) had generalized dystonia, involving oromandibular muscles in 3 cases and the larynx in 2 of these. In the only patient with axial onset, the condition had progressed to segmental dystonia (upper limb involvement) without generalization, after 19 years.
Age at generalization was 13.5 Ϯ 5.3 years (range, 7-23 years); time from onset to generalization was 3.1 Ϯ 2.6 years (range, 1-10 years). The rate of disease progression in upper limb-onset patients was similar that that in lower limb-onset patients. Symptom spread increased significantly with disease duration (P Ͻ 0.001; Fig. 1 ).
All DYTI cases received anticholinergics titrated up to the maximum tolerated dose. Slight to moderate benefit was obtained in most cases. Baclofen was given as second-choice medication to patients who did not tolerate or did not benefit from anticholinergics.
Non-DYT1 Cases
In 43 patients (75%, 27 men, 16 women; ratio, 1.7:1), a DYT1 mutation was not found. All except 1 of these was Caucasian, the other was a Sephardic Jew. Seven patients (16%) had a family history of dystonia, 36 (84%) were sporadic. Mean age at onset was 8.7 Ϯ 4.3 years (range, 2-17 years). A total of 34 (79%) had limb onset (lower limb in 16, upper limb in 18), 6 had cervical onset, 2 had axial onset, and 1 had oromandibular onset. Those with upper limb onset did not differ in age from those with lower limb onset, whereas limb-onset patients had earlier onset age than cervical-onset patients (P ϭ 0.005 cervical vs. lower limb; P Ͻ 0.05 cervical vs. upper limb).
At latest examination, mean disease duration was 16.0 Ϯ 11.1 years (range, 2-52 years); 29 (67%) had generalized dystonia, with oromandibular involvement in 17 (59%) of these and laryngeal involvement in 4. One generalized case had laryngeal, but not oromandibular involvement. Dystonia was segmental in 8 (19%), and multifocal in 1 (2%). The dystonia remained focal (after 10.2 Ϯ 6.3 years of disease) in 5 (12%).
Patients with generalized dystonia had earlier onset than those without generalization (7.1 Ϯ 3.6 vs. 12.0 Ϯ 3.9; P Ͻ 0.001). Generalized dystonia occurred in 79% of patients with limb onset compared to only 22% without limb onset (P Ͻ 0.005); disease duration was comparable in the groups with and without limb onset.
Age at generalization was 9.2 Ϯ 4.0 years (range, 4 -20 years); time between onset and generalization was 2.2 Ϯ 1.5 years (range, 1-7 years). Progression to a second body area occurred faster in patients with lower limb than upper limb onset (P Ͻ 0.05). By contrast, time to progression from second to third or subsequent site did not differ between upper limb-and lower limb-onset patients.
Non-DYT1 patients with sporadic dystonia had more rapid progression than those with familial occurrence. Times to involvement of a second, third, fourth site, and to generalization were much shorter in sporadic than in familial patients (P Ͻ 0.01, P ϭ 0.01, P ϭ 0.05, P ϭ 0.05, respectively), thus identifying 2 clinically distinct subgroups of non-DYT1 patients (Fig. 2) . Non-DYT1 patients received the same therapeutic protocol as DYT1 patients, which, however, provided appreciable benefit in a few cases only.
Familial non-DYT1 Cases
The 7 familial non-DYT1 index cases consisted of 2 men and 5 women (ratio, 0.4:1). All were of Caucasian origin and belonged to 7 unrelated families. One patient was the proband of a well-characterized family with disease linked to the DYT13 locus. 22 The prevalent phenotype was cervical district involvement with less frequent generalization than DYT1 and sporadic non-DYT1 forms, notwithstanding fealty to early onset age (13.9 Ϯ 2.0 years; range, 1-17 years; generally later than other forms).
Cervical onset occurred in 3 of the 7 familial cases (43%); limb onset occurred in the remaining 4 (two upper limb, two lower). At latest examinations (22.0 Ϯ 13.6 yr after onset; range, 13-52 years) 3 of the familial non-DYT1 cases (43%) had generalized dystonia. The cases without generalization (2 segmental and 1 focal) had cervical dystonia; 2 of these also had cranial involvement.
Between-Group Comparisons
DYT1 and non-DYT1 patients did not differ in terms of sex ratio, onset age, time to generalization, or proportion with laryngeal, cervical, and limb onset. Progression to second, third, and fourth site and generalization was also similar in both groups. By contrast, non-DYT1 patients more often had cranial involvement and earlier generalization (P Ͻ 0.01 and Ͻ 0.05, respectively, Table  1 ; Fig. 3) . Analysis of the sensitivity and specificity of onset site for the diagnosis of DYT1 dystonia revealed   FIG. 1 . Dystonia progression as assessed by increase in number of involved sites per year. There was no difference in progression between DYT1 (n ϭ 14) and non-DYT1 patients (n ϭ 43).
FIG. 2.
Dystonia progression curves as assessed by time to generalized dystonia. Curves are shown for DYT1, familial non-DYT1, and sporadic non-DYT1 patients. Familial non-DYT1 patients had less severe progression than sporadic non-DYT1 patients and DYT1 patients (P Ͻ 0.05).
no useful values. Both cranial and cervical onset were characterized by very low sensitivity (6%) and specificity of approximately 70%; limb onset had low sensitivity and low specificity. The likelihood of being a carrier of a mutation in the DYT1 gene was 1.4 in patients with limb onset and 0.2 in patients with onset not in a limb. With regard to upper and lower limb onset, we found that lower limb onset was more characteristic of DYT1 dystonia (likelihood ratio, 1.7), whereas upper limb onset had a likelihood ratio of 1; thus, a patient with arm onset had equal probabilities of having and of not having the DYT1 mutation.
DYT1 patients differed markedly from familial non-DYT1 cases. The latter had older age at onset and older age at generalization, more frequent cervical involvement and less common limb onset (Table 1) .
Burke & Fahn-Marsden scale disability scores were available for 44 patients (9 DYT1 and 35 non-DYT1). Mean disability scores at latest evaluation did not differ in these groups (DYT1 8.9 Ϯ 7.3; non-DYT1 9.3 Ϯ 5.9) and did not correlate with age at onset.
DISCUSSION
Early-onset PTD is progressive, usually resulting in severe disability 3 ; clinical presentation is variable although limb onset occurs more often in DYT1 patients. The DYT1 form has been well studied, whereas the phenotype of EO-PTD in patients not carrying the DYT1 mutation is poorly known. Table 2 provides a synopsis of the non-DYT1 EO-PTD cases published so far. From Table 2 , two main phenotypes are discernible: a mainly focal type with upper limb, cervical, or cranial involvement, and a so-called "mixed phenotype," 23 observed in DYT6, 24 DYT13, 22 and other reported cases.
Like previous studies, 22,25-27 we found that cervical involvement occurred (inconstantly) in non-DYT1 cases. In our series, no DYT1 case had cervical involvement; such involvement is reported only rarely in DYT1 dystonia. 9 These findings better characterize the extent of phenotypic overlap between DYT1 and non-DYT1 forms. We also found that non-DYT1 patients had a more heterogeneous phenotype than DYT1 cases. The typical phenotype in our DYT1 patients was limb onset and progression to generalized dystonia, whereas patients with cranial or cervical onset were unlikely to have the DYT1 mutation.
Cranial onset before 21 years had low sensitivity but high specificity for the exclusion of DYT1 dystonia, providing further evidence that DYT1 dystonia with cranial onset is uncommon. Limb onset had low sensitivity and low specificity for exclusion of DYT1 dystonia, indicating that limb onset is not uncommon in either DYT1 or non-DYT1 forms. When onset was in an upper limb, the probability of having DYT1 dystonia was equal to that of not having it; whereas when onset was in a lower limb, the probability of having DYT1 dystonia was greater.
The phenotype of DYT1 patients in the present series is consistent with previous observations. Mean age at onset was similar to the 9.9 Ϯ 4.3 years reported for mainly British patients, 28 and with the onset age of 12.5 Ϯ 8.2 years found in Ashkenazi Jews. 29 The majority of observed DYT1 cases (94%) had limb onset, as is commonly observed in Ashkenazi Jews. 29 Only one reported DYT1 case-a sporadic Japanese patient 30 has been reported with axial onset. European series of non-Jewish DYT1 cases have generally been characterized by greater variation in presentation and dystonia distribution than Ashkenazi populations. 11, 31, 32 Notwithstanding the variation in site of onset, progression to a generalized form is the norm in EO-DYT1 patients. 9 This finding was also the case in our series, where all except one DYT1 patient progressed to generalization.
The present study indicates that the DYT1 mutation is not the most common cause of EO-PTD in Italy, with non-DYT1 cases three times more frequent that DYT1 cases. This finding is consistent with previous data, in which DYT1 cases formed 7.9% of the total in Serbia, 33 15% in Denmark, 34 and 16% in Italy. 35 By contrast, DYT1 patients accounted for 62% of early onset generalized cases in Russia. 36 The higher prevalence of DYT1 cases in Russia and also in North America 29 is probably related to the larger populations of Ashkenazi Jews in those countries.
To conclude, our study highlights some clear clinical differences between the various categories of EO-PTD. Sporadic non-DYT1 cases had the highest incidence of cranial involvement (much higher than in DYT1 patients). Except for this feature, however, the phenotype of sporadic non-DYT1 patients overlapped considerably with that of DYT1 cases. In keeping with this overlap, progression curves for sporadic non-DYT1 cases overlapped with those of DYT1 patients. Familial non-DYT1 cases also differed from sporadic non-DYT1 and DYT1 patients in that they progressed more slowly and had a relatively homogeneous phenotype, comparable to the "mixed phenotype" 23 and characterized by cervical involvement, frequent nonlimb onset, and relatively benign disease course with uncommon generalization. This finding raises the possibility that other genetic defects are responsible for the dystonia in these familial cases. Pooling these cases for linkage analysis may reveal whether or not they are associated with a common locus, paving the way for investigations similar to those already performed on the DYT1 gene. 
LEGEND TO THE VIDEO
The videotape shows three early-onset primary torsion dystonia patients with limb onset and slow progression.
Patient 1: This patient had the GAG deletion in the DYT1 gene. He developed task-specific dystonia in the right lower limb at 9 years of age, which subsequently progressed to a generalized form. The first segment shows the patient at 11 years of age, 2 years after onset when all limbs are affected, with clumsiness of movements in the upper limbs and impaired gait, with outward rotation of the right lower limb. The second segment shows the patient at 14 years of age. Dystonia can also be observed at rest in the right lower limb; during attempted voluntary movement, there is abnormal extensor posture of leg and flexion of the right foot.
Patient 2: This is a sporadic non-DYT1 patient, who presented dystonia at 6 years of age. The right upper limb was affected first. The dystonia subsequently progressed without involving the lower limbs. The first segment shows the patient 6 months after onset. Action dystonia is evident in the right upper limb, left hand movements are clumsy, but the patient walks without difficulty. Segment 2 shows the patient at age 14; he has severe upper limb, cervical, and trunk dystonia. Remarkably, the lower limbs are spared.
Patient 3: Shown is a sporadic non-DYT1 patient who developed dystonia at 8 years if age. The disease started in the right upper limb and slowly spread to the contralateral upper limb, then mildly affected the trunk before stabilizing with no further progression. Segment 1 shows the patient at age 10: action dystonia of both upper limbs is obvious. Segment 2 shows the patient at age 16: severe dystonia occurs in both upper limbs and there is minimal trunk involvement.
